相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inflammation in Experimental Models of α-Synucleinopathies
Ashley S. Harms et al.
MOVEMENT DISORDERS (2021)
Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk
Austin P. Passaro et al.
FRONTIERS IN IMMUNOLOGY (2021)
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa et al.
NATURE REVIEWS NEUROLOGY (2020)
Parkinson disease and the immune system - associations, mechanisms and therapeutics
Eng-King Tan et al.
NATURE REVIEWS NEUROLOGY (2020)
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson's disease pathogenesis
Lifu Sheng et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)
The Role of α-Synuclein Oligomers in Parkinson's Disease
Xiao-yu Du et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Erythrocytic α-Synuclein as a potential biomarker for Parkinson's disease
Chen Tian et al.
TRANSLATIONAL NEURODEGENERATION (2019)
Increased Immune Activation by Pathologic α-Synuclein in Parkinson's Disease
Veselin Grozdanov et al.
ANNALS OF NEUROLOGY (2019)
B cells in autoimmune and neurodegenerative central nervous system diseases
Joseph J. Sabatino et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
Francesca Garretti et al.
FRONTIERS IN IMMUNOLOGY (2019)
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
Javier Campos-Acuna et al.
FRONTIERS IN IMMUNOLOGY (2019)
LRRK2 phosphorylates membrane-bound Rabs and is activated by GTP-bound Rab7L1 to promote recruitment to the trans-Golgi network
Zhiyong Liu et al.
HUMAN MOLECULAR GENETICS (2018)
The localization of α-synuclein in the process of differentiation of human erythroid cells
Katsuya Araki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2018)
Alpha-synuclein dimerization in erythrocytes of patients with genetic and non-genetic forms of Parkinson's Disease
Nikolaos Papagiannakis et al.
NEUROSCIENCE LETTERS (2018)
α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson's Disease Patients and Correlate with Disease Severity
Simona Daniele et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Toll-like receptor 2 is increased in neurons in Parkinson's disease brain and may contribute to alpha-synuclein pathology
Nicolas Dzamko et al.
ACTA NEUROPATHOLOGICA (2017)
Wild-Type Monomeric α-Synuclein Can Impair Vesicle Endocytosis and Synaptic Fidelity via Tubulin Polymerization at the Calyx of Held
Kohgaku Eguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
Junichi Matsumoto et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
LRRK2 levels in immune cells are increased in Parkinson'sdisease
D. A. Cook et al.
NPJ PARKINSONS DISEASE (2017)
G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons
Laura A. Volpicelli-Daley et al.
JOURNAL OF NEUROSCIENCE (2016)
Role of neuroinflammation in neurodegenerative diseases
Wei-Wei Chen et al.
MOLECULAR MEDICINE REPORTS (2016)
Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease A Systematic Review and Meta-analysis
Xiao-Yan Qin et al.
JAMA NEUROLOGY (2016)
LRRK2 contributes to monocyte dysregulation in Parkinson's disease
Corinna Bliederhaeuser et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Dynasore enhances the formation of mitochondrial antiviral signalling aggregates and endocytosis-independent NF-B activation
M. Ailenberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration
Joao P. L. Daher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease
Xuemei Wang et al.
NEUROSCIENCE LETTERS (2015)
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibitions
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Inflammatory dysregulation of blood monocytes in Parkinson's disease patients
Veselin Grozdanov et al.
ACTA NEUROPATHOLOGICA (2014)
THP-1 cell line: An in vitro cell model for immune modulation approach
Wasaporn Chanput et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2014)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes
Towfique Raj et al.
SCIENCE (2014)
Neural and Immune Mechanisms in the Pathogenesis of Parkinson's Disease
Fabio Blandini
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Clathrin-Mediated Endocytosis Persists during Unperturbed Mitosis
Silvia K. Tacheva-Grigorova et al.
CELL REPORTS (2013)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease
Louise M. Collins et al.
NEUROPHARMACOLOGY (2012)
IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease (vol 2, e142, 2011)
C. Barcia et al.
CELL DEATH & DISEASE (2012)
Parkinson's Disease: Genetics and Pathogenesis
Joshua M. Shulman et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Monocyte recruitment during infection and inflammation
Chao Shi et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Minimal penetration of lipopolysaccharide across the murine blood-brain barrier
William A. Banks et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated α-synuclein gene mutations precede central nervous system changes
Yien-Ming Kuo et al.
HUMAN MOLECULAR GENETICS (2010)
Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling
Mirkka Koivusalo et al.
JOURNAL OF CELL BIOLOGY (2010)
Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease
Min Shi et al.
NEUROSCIENCE LETTERS (2010)
Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells
Anton I. Rosenbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Interleukin-10: new perspectives on an old cytokine
David M. Mosser et al.
IMMUNOLOGICAL REVIEWS (2008)
Parkinson's disease: clinical features and diagnosis
J. Jankovic
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Red blood cells are the major source of alpha-synuclein in blood
Robin Barbour et al.
NEURODEGENERATIVE DISEASES (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Peripheral inflammatory biomarkers and risk of Parkinson's disease
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Expression of α-synuclein, a presynaptic protein implicated in Parkinson's disease, in erythropoietic lineage
Masaaki Nakai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
IL-10-producing macrophages preferentially clear early apoptotic cells
Wei Xu et al.
BLOOD (2006)
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease
Omar M. A. El-Agnaf et al.
FASEB JOURNAL (2006)
Aggregated α-synuclein activates microglia:: a process leading to disease progression in Parkinson's disease
W Zhang et al.
FASEB JOURNAL (2005)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Genomic medicine: Alzheimer's disease and Parkinson's disease
RL Nussbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Neuroinflammatory processes in Parkinson's disease
S Hunot et al.
ANNALS OF NEUROLOGY (2003)
Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration
PL McGeer et al.
ANNALS OF NEUROLOGY (2003)
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain
M Mogi et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
